Skip to main content

Applied Genetic Technologies Corporation (AGTC)

NASDAQ: AGTC · IEX Real-Time Price · USD
2.24 0.26 (12.88%)
Dec 7, 2021 1:52 PM EST - Market open
Market Cap95.80M
Revenue (ttm)500,000
Net Income (ttm)-59.57M
Shares Out42.86M
EPS (ttm)-1.61
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume762,847
Open1.99
Previous Close1.98
Day's Range1.99 - 2.28
52-Week Range1.85 - 9.67
Beta1.93
AnalystsStrong Buy
Price Target16.00 (+615.9%)
Earnings DateNov 9, 2021

About AGTC

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has in...

IndustryBiotechnology
IPO DateMar 27, 2014
CEOSusan Washer
Employees83
Stock ExchangeNASDAQ
Ticker SymbolAGTC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for AGTC stock is "Strong Buy." The 12-month stock price forecast is 16.00, which is an increase of 615.88% from the latest price.

Price Target
$16.00
(615.88% upside)
Analyst Consensus: Strong Buy

News

AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors

Robinson's expertise in development and commercialization adds to the clinical and commercial experience of newly appointed management team Robinson's expertise in development and commercialization adds...

1 day ago - GlobeNewsWire

AGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

3 weeks ago - GlobeNewsWire

AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalmology 2021 Annual...

- Poster presentation highlights safety and efficacy potential of AGTC-501 as a treatment for X-linked retinitis pigmentosa (XLRP) - - Poster presentation highlights safety and efficacy potential of AGT...

3 weeks ago - GlobeNewsWire

Applied Genetic Technologies (AGTC) Reports Q1 Loss, Lags Revenue Estimates

Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for...

4 weeks ago - Zacks Investment Research

AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2021

-Company on track to provide multiple data readouts for XLRP and ACHM clinical programs in 2021 and 2022-

4 weeks ago - GlobeNewsWire

AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 9, 2021

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

1 month ago - GlobeNewsWire

AGTC to Present at Upcoming Dry AMD Therapeutic Development Summit

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

1 month ago - GlobeNewsWire

AGTC Announces Two Key Leadership Team Appointments

- AGTC Welcomes Susan Schneider as the Chief Medical Officer and Sarah C. DiSalvatore as the Vice President of Clinical Operations - - AGTC Welcomes Susan Schneider as the Chief Medical Officer and Sara...

1 month ago - GlobeNewsWire

AGTC to Present at Upcoming Cell & Gene Meeting on the Mesa

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

1 month ago - GlobeNewsWire

AGTC to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

2 months ago - GlobeNewsWire

Kids Suffer Adverse Reactions In Applied Genetic's Color Blindness Gene Therapy Trial

After escalating the dose in its pediatric gene therapy trial, Applied Genetic Technologies Corporation (NASDAQ: AGTC) has run into safety problems.  The Company recently enrolled six pediatric achromat...

2 months ago - Benzinga

AGTC Provides Financial Results for the Fourth Quarter and Year Ended June 30, 2021

-Data from ongoing clinical trials in XLRP and ACHM shows evidence of clinical activity and tolerability; multiple data readouts expected in 2021 and 2022-

2 months ago - GlobeNewsWire

AGTC to Host Fourth Quarter and 2021 Fiscal Year End Financial Results Conference Call and Webcast on September 23, 2021

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

2 months ago - GlobeNewsWire

AGTC to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

3 months ago - GlobeNewsWire

AGTC to Present at the 2021 Wells Fargo Virtual Healthcare Conference

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

3 months ago - GlobeNewsWire

Greater Gift, AGTC, and 2020 On-site Partner To Honor & Celebrate Clinical Trial Participants and Provide Eye Exams t...

WINSTON SALEM, N.C., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Greater Gift of Winston Salem, a non-profit that celebrates participation in clinical trials today announced a partnership with Applied Genetic Tec...

3 months ago - GlobeNewsWire

AGTC Announces Sponsorship of Achroma Corp's No Roadblocks Program

- Program helps those living with Achromatopsia receive filtered glasses and contact lenses to qualify for bioptic driving-

3 months ago - GlobeNewsWire

AGTC Appoints Ophthalmology and Retinal Disease Specialist and Industry R&D Veteran Yehia Hashad, MD to its Board of ...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

3 months ago - GlobeNewsWire

AGTC to Participate in Envision Virtual Conference East 2021 Panel Discussion

-AGTC patient advocacy executive director will address genetic testing and gene therapy for the treatment of rare retinal diseases-

3 months ago - GlobeNewsWire

AGTC to Participate at Upcoming Investor Conferences

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

4 months ago - GlobeNewsWire

AGTC Reports 12-Month Data from its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Pati...

- Activities to support the next stage of clinical development of ACHM B3 candidate are ongoing-

5 months ago - GlobeNewsWire

AGTC to Host Conference Call on June 24 at 8:00 AM ET to Discuss Achromatopsia 12-Month Data in its Ongoing CNGB3 and...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

5 months ago - GlobeNewsWire

AGTC to Present at American Optometric Association's Optometry's Meeting

-AGTC patient advocacy executive director will highlight the state of gene therapy  trial recruitment for IRDs-

5 months ago - GlobeNewsWire

Is the Options Market Predicting a Spike in Applied Genetic Technologies (AGTC) Stock?

Investors need to pay close attention to Applied Genetic Technologies (AGTC) stock based on the movements in the options market lately.

5 months ago - Zacks Investment Research

7 Penny Stocks To Watch Before They Pop Due to Reddit Users

Penny stocks are not usually on lists of must-buy stocks, but that does not mean these companies cannot explode in the coming weeks. The post 7 Penny Stocks To Watch Before They Pop Due to Reddit Users ...

5 months ago - InvestorPlace